Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1874478Erstellt: 26. Oktober 2026

Oxalyl chloride → 3-cyclopropyl-N-[3-({2-[(cyclopropylcarbonyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}oxy)phenyl]-1-methyl-1H-pyrazole-4-carboxamide

https://huagongshe.com/reaction/1874478

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktOxalyl chlorideHCID 65578—
Edukt3-cyclopropyl-1-methyl-1H-pyrazole-4-carboxylic acidHCID 19576794—
Edukt5-cyclopropyl-1-methyl-1H-pyrazole-4-carboxylic acidHCID 29049288—
EduktN-[6-(3-aminophenoxy)[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamideHCID 57749117—
KatalysatorDimethylformamideHCID 6228—
LösungsmittelWaterHCID 962—
LösungsmittelTetrahydrofuranHCID 8028—
Produkt3-cyclopropyl-N-[3-({2-[(cyclopropylcarbonyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}oxy)phenyl]-1-methyl-1H-pyrazole-4-carboxamideHCID 5774913620%

Reaktionsschritte

To a mixture of 3-cyclopropyl-1-methyl-1H-pyrazole-4-carboxylic acid and 5-cyclopropyl-1-methyl-1H-pyrazole-4-carboxylic acid (430 mg, 2.59 mmol) in tetrahydrofuran (7 mL) were added oxalyl chloride (338 μL, 3.87 mmol) and N,N-dimethylformamide (1 drop), and the mixture was stirred at room temperature for 1 hr. The reaction mixture was concentrated under reduced pressure, and the residue was dissolved in N,N-dimethylacetamide (3 mL). N-[6-(3-Aminophenoxy)[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide (400 mg, 1.29 mmol) was added with stirring under ice-cooling, and the mixture was stirred at room temperature for 15 hr. The reaction mixture was diluted with water and extracted with ethyl acetate. The organic layer was washed with water and saturated brine, dried over anhydrous magnesium sulfate and filtrated. The filtrate was concentrated under reduced pressure, and the residue was purified by column chromatography (NH silica gel, hexane/ethyl acetate=70/30→0/100), and then by column chromatography (silica gel, ethyl acetate/methanol=95/5) and recrystallized from ethyl acetate to give the title compound (120 mg, 20%) as a white solid.

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS08304557B2
Quelldatensatzuspto-grants-2012_11
ORD IDord-40f2425bff2e4fb1b4417beee88a7e0e
Quellennotizuspto-grants-2012_11